Mupina (Mupirocin)

Mupirocin, the active ingredient in Mupina, is an antibiotic presented as a nasal preparation for intranasal use. It treats bacterial colonisation of the nasal passages, particularly Staphylococcus aureus, including methicillin‑resistant strains, and is employed to reduce infection risk in at‑risk patients.

GNH USA supplies Mupina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution across EU and other markets. The company adheres to stringent quality standards and provides regulatory support for global procurement.

Mupirocin is used to eradicate bacterial colonisation in the nasal cavity, primarily targeting Staphylococcus aureus.

- Nasal carriage of Staphylococcus aureus: reduces bacterial colonisation and lowers the risk of subsequent infection. - Pre‑operative decolonisation: prepares patients for surgery by decreasing postoperative surgical site infection rates. - Dialysis catheter care: helps prevent catheter‑related infections in carriers undergoing haemodialysis.

Mupirocin nasal application may cause local and systemic adverse reactions, ranging from mild irritation to rare serious events.

Common Side Effects: - Nasal irritation - Burning sensation - Itching - Headache

Serious or Rare Side Effects: - Allergic contact dermatitis - Anaphylaxis - Stevens‑Johnson syndrome

When using Mupina, certain precautions should be observed to ensure safety and effectiveness.

- Pregnancy: consult a healthcare professional before use. - Breastfeeding: weigh potential risks and benefits with a clinician. - Allergy: avoid if known hypersensitivity to mupirocin or formulation excipients. - Extensive nasal lesions: do not apply to damaged or ulcerated mucosa. - Duration of therapy: limit use to the prescribed period to reduce resistance. - Store at room temperature: keep in original container, protect from moisture and light.

Mupirocin has limited systemic absorption, yet certain drug interactions merit attention.

Major Interactions (Avoid): - Concurrent use with other topical antibiotics: may increase risk of local resistance. - Systemic aminoglycosides: additive nephrotoxic potential if systemic absorption occurs (rare).

Moderate Interactions (Monitor Closely): - Antifungal agents applied to the same site: may alter local flora. - Immunosuppressants: monitor for infection signs. - Oral antibiotics targeting Gram‑positive bacteria: possible additive effect on normal flora.